1. Afifi, A. K., Mire-Salman, J., & Najjar, S. (1976). The myopathology of congenital generalized lipodystrophy light and electron microscopic observations. The Johns Hopkins Medical Journal, 139, 61–68.
2. Agarwal, A. K., & Garg, A. (2003). Congenital generalized lipodystrophy: Significance of triglyceride biosynthetic pathways. Trends in Endocrinology and Metabolism, 14, 214–221.
3. Agarwal, A. K., & Garg, A. (2006). Genetic basis of lipodystrophies and management of metabolic complications. Annual Review of Medicine, 57, 297–311.
4. Agarwal, A. K., Arioglu, E., De Almeida, S., et al. (2002). AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nature Genetics, 31, 21–23.
5. Agarwal, A. K., Simha, V., Oral, E. A., et al. (2003). Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. Journal of Clinical Endocrinology and Metabolism, 88, 4840–4847.